50 diseases, 70 new molecular entities, 165 clinical development projects.
Our Head of Global #DrugDevelopment and CMO John Tsai shares how we prioritize and advance the right programs across our #pipeline that will deliver the highest impact for patients.
https://twitter.com/Novartis/status/1480894296366759937
Posted on Twitter/X ·
22
6
1
22
6
1
Suggested Credits
Credits on Gondola describe each credited role and may be incomplete. A brand or featured person is not necessarily the creator.